DIA401.02+0.04 0.01%
SPX5,525.21+40.44 0.74%
IXIC17,382.94+216.90 1.26%

Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results

Benzinga·03/20/2025 14:24:07
Listen to the news

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.25% to 42,070.99 while the NASDAQ climbed 0.37% to 17,817.11. The S&P 500 also rose, gaining, 0.28% to 5,689.83.

Check This Out: Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday

Leading and Lagging Sectors

Consumer discretionary shares rose by 0.7% on Thursday.

In trading on Thursday, materials shares fell by 0.3%.

Top Headline

Shares of Accenture Plc (NYSE:ACN) fell more than 7% on Thursday after the company reported results for the second quarter.

The company reported second-quarter 2025 earnings of $2.82 per share, slightly above the consensus of $2.81. The company reported sales of $16.66 billion, almost in line with the consensus of $16.62 billion and management guidance of $16.2 billion–$16.8 billion.

Accenture narrowed its fiscal year 2025 revenue growth outlook to 5%-7% in local currency, compared to prior guidance of 4%-7%. The company forecasts 2025 diluted earnings of $12.55-$12.79 per share compared to the consensus of $12.90.

Equities Trading UP
                       

  • SAG Holdings Limited (NASDAQ:SAG) shares shot up 107% to $1.3995.
  • Shares of Windtree Therapeutics, Inc. (NASDAQ:WINT)got a boost, surging 59% to $2.6900 after the company entered a license and supply agreement to become a sourcing partner for Evofem Biosciences for Evofem’s PHEXXI.
  • OptiNose, Inc. (NASDAQ:OPTN) shares were also up, gaining 57% to $9.39 after Paratek Pharmaceuticals announced it will acquire the company in a deal worth $330 million.

Equities Trading DOWN

  • Elevation Oncology, Inc. (NASDAQ:ELEV) shares dropped 47% to $0.2501 after the company announced the discontinued development of EO-3021.
  • Shares of Benson Hill, Inc. (NASDAQ:BHIL) were down 45% to $0.3570 after the company filed for Chapter 11 bankruptcy.
  • Adaptimmune Therapeutics plc (NASDAQ:ADAP) was down, falling 31% to $0.3088 after the company issued fourth-quarter and full year 2024 business update.

Commodities

In commodity news, oil traded up 0.5% to $67.50 while gold traded down 0.1% at $3,040.20.

Silver traded down 0.6% to $33.985 on Thursday, while copper fell 0.4% to $5.0815.

Euro zone

European shares were lower today. The eurozone's STOXX 600 fell 0.4%, Germany's DAX 40 fell 1.2% and France's CAC 40 fell 0.8%. Spain's IBEX 35 Index fell 0.9%, while London's FTSE 100 slipped 0.1%.

Asia Pacific Markets

Asian markets closed mixed on Thursday, with China's Shanghai Composite Index falling 0.51%, Hong Kong's Hang Seng Index dipped 2.23% and India's BSE Sensex gaining 1.19%.

Economics

  • U.S. existing home sales increased by 4.2% from the previous month to an annualized rate of 4.26 million homes in February.
  • The U.S. current account deficit shrank by 2.0% to $303.9 billion in the fourth quarter, versus a revised deficit of $310.3 billion in the third quarter.
  • U.S. initial jobless claims increased by 2,000 to 223,000 during the second week of March, compared to market estimates of 224,000.
  • The Philadelphia Fed Manufacturing Index fell to 12.5 in March from 18.1 in the previous month, versus market estimates of 8.5.

Now Read This:

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.